老司机传媒

Ruben de Jesus, Pahti膩 Technologies

Learn more about a startup working to improve cancer treatment outcomes

Location: Chan Shun Hall, Garber Auditorium

Date and Time: Mar. 11, 11:30 a.m.

Description:

Over the past 10-15 years, targeted therapies for cancer have greatly increased survivability rates of patients in the USA, Europe, and Japan. However, access to the data needed to prescribe targeted therapies varies by country and without this knowledge the treatment options are limited for a patient. Moreover, existing targeted therapies were created for the cancers that most affect European-heritage populations and the cancer burden differs across populations. We see this then as a data and global health equity problem.

. is a global health technology data company leveraging next generation sequencing and artificial intelligence to increase access to targeted therapies for cancer in under-researched populations. Our ultimate goal is to enhance health equity around the world in the fight against cancer.

Website: 

Speaker: